Press releases from PBD Biotech

You can view our press releases in pdf format via the links below.

July 2023: Actiphage TB awarded US Patent grant for diagnostic kit

July 2023: Actiphage TB enters new third clinical trial aimed at early validating tuberculosis diagnostic utility

May 2023: Phage-based diagnostics and the fight against infectious disease

May 2023: New Centre for Phage Research features Actiphage within Innovation Showcase

April 2023: Potential for Actiphage to provide ‘test of cure’ for new TB drugs

March 2023: PBD Biotech’s novel lyophilized PCR reaction bead reduces cost of transport and extends shelf-life for active TB test

February 2023: PBD Biotech expands its patent protection for incipient TB test Actiphage

January 2023: PBD Biotech appoint Dr Marie Roskrow as chair

October 2022: PBD Biotech Raises Further £2.4m for its breakthrough tuberculosis blood test

September 2022: Actiphage selected for evaluation by R2D2 TB network

July 2022: Mondana Cook joins PBD Biotech to bring human TB diagnostic to market

April 2022: Actiphage TB blood test finds live mycobacterium tuberculosis in the blood of people with incipient TB

March 2022: Could Actiphage provide rapid TB test in sub-Saharan Africa?